PREVENT 2023 10-year CVD Risk (race-free)
Calculate the 10-year total cardiovascular-disease risk using the American Heart Association PREVENT equations (2023) - the race-free successor to the Pooled Cohort Equations.
Open the calculator → Runs in your browser. Data leaves only if you deliberately send a problem report from the interactive tool.
Example
- Age
- 55 years
- Total cholesterol
- 200 mg/dL
- HDL cholesterol
- 50 mg/dL
- Systolic BP
- 120 mmHg
- BMI
- 25 kg/m^2
- eGFR
- 90 mL/min/1.73m^2
- Sex
- M
Result: PREVENT 10-year total CVD risk lands in the borderline / low band for a healthy 55-year-old.
The tool opens with these values already filled in. Replace them with your own.
What the result means
- <5%
- Low 10-year total cardiovascular disease risk.
- 5-9.9%
- Borderline 10-year total CVD risk.
- 10-19.9%
- Intermediate 10-year total CVD risk.
- >=20%
- High 10-year total CVD risk.
What you enter
- Age (30-79)
- Total cholesterol
- HDL cholesterol
- Systolic BP
- BMI
- eGFR
- Sex
- On treatment for hypertension
The other 2 fields
- Smoker
- Diabetes
What this is
PREVENT takes age, sex, total cholesterol, HDL, systolic blood pressure, BMI, and eGFR and returns the 10-year probability of a first hard cardiovascular event combining MI, stroke, and heart-failure outcomes. Sophie Well runs the base total-CVD equation only and does not include the optional UACR, HbA1c, or social-deprivation extensions. Source: Khan SS et al. Circulation 2024;149:430-449.
When to use it
Use this in primary care for an adult age 30-79 without known atherosclerotic cardiovascular disease to anchor a shared decision about statin therapy, antihypertensive intensification, and lifestyle intervention. PREVENT is calibrated for a contemporary US population and replaces race as an input - the variable that drove much of the equity criticism of the older PCE - while adding heart-failure outcomes to the composite. It is not a treatment threshold; the 2024 ACC/AHA primary-prevention guidance pairs PREVENT output with risk-enhancing factors, coronary artery calcium scoring, and patient preference before prescribing.
How this is calculated
Khan SS, et al. Development and Validation of the AHA PREVENT Equations. Circulation. 2024;149(6):430-449, online November 2023 -- the year in this tool's name. PREVENT is race-FREE, unlike the PCE. Base 10-yr total CVD equation only (no statin / antihypertensive use, UACR, HbA1c, or SDI terms). Read the source ↗
A reference and educational tool. Not medical, legal, or financial advice, and not a substitute for clinician judgment.
More in Cardiology.